Replies to post #100181 on Biotech Values

[read_this_n0w]

Retinopathy Neuroprotective therapy for very preterm birth


Diarienummer : REGSKANE-133321 Registration number: 133 321-REGSKANE
Projektanslag för år 2011 och 2012 Project Appropriations for 2011 and 2012


http://translate.google.nl/translate?hl=nl&sl=sv&tl=en&u=http://www.researchweb.org/is/sverige/ansokan/133321

[DewDiligence]

CRL just cut its 2010 guidance significantly:

http://www.reuters.com/article/idCNSGE66T11720100802

A cynic might say that the failed attempt to acquire WX was a diversionary tactic.